Thursday May 24, 2018 16:58

Food and Healthcare Press Releases

The Mall Shopping Center and Government Savings Bank Co-host The Mall Health Beauty Expo 2018 Heathcare—17 May 18

The Mall Shopping Center, Government Savings Bank, leading hospitals and health institutions are co-hosting an annual grand event, "The Mall Health & Beauty Expo 2018" on June 28 – July 4, 2018 at the Grand Hall, G Floor, The Mall Bangkapi.

Real-World Evidence Shows Clinically Meaningful Weight Loss in People Receiving Saxenda(R) Heathcare—24 May 18

VIENNA--24 May--PRNewswire/InfoQuest

People treated with Saxenda(R) (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. The data were presented this week at both the 25th European Congress on Obesity (ECO 2018) in Vienna, Austria and the 23rd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR 2018) in Baltimore, US.[1],[2]

This retrospective effectiveness study investigated the impact of Saxenda(R) treatment in people with overweight and obesity across six weight management clinics in Canada. After six months, people treated with Saxenda(R) as an adjunct to diet and exercise achieved 7.1% weight loss from baseline, with 63.4% and 35.2% of people losing ≥5% and >10% of their body weight, respectively.[1],[2] Results from the real-world study were in line with those observed in the SCALE clinical trial programme.[3]

"Obesity is a chronic and multifactorial disease, requiring a range of treatment options to help people achieve and maintain weight loss," said Dr Sean Wharton of the Wharton Medical Clinic, Toronto, Canada and lead investigator of this study. "Weight loss of 5 to 10% can have significant health benefits, including reducing the risk of developing cardiov

Venus Medtech#s strategic investment in Keystone Heart deepens the technical layout of cerebral Heathcare—24 May 18

China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right to exclusively develop, manufacture and sell the 3rd generation

WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Heathcare—23 May 18

WCG(TM) (WIRB-Copernicus Group(R)) Clinical Services Division, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the opening of the company's new office in Tokyo, Japan.

Head-to-Head Trial Shows Refixia(R) Achieves Greater Total Factor IX Exposure in People With Heathcare—21 May 18

Adults with haemophilia B who received a single dose Refixia(R) (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those treated with rFIXFc (recombinant factor IX-Fc fusion protein). The head-to-head paradigm7 trial also observed

NovoEight(R) Maintains Potency When Stored at 40?C Offering People With Haemophilia A Increased Heathcare—21 May 18

A new long term stability study has shown that haemophilia A treatment NovoEight(R) (turoctocog alfa) remains potent after three months exposure to temperatures of 40ºC.[1] The results were presented today at the WFH 2018 World Congress in Glasgow,

Merck Data at ASCO 2018 to Showcase Progress and Further Optionality of Oncology Heathcare—17 May 18

ASCO Abstract # ERBITUX(R) (cetuximab): 3521, 3534, e15711; avelumab: 9507, 9537, 9090, 9008, 8563, 3057, 4544, e21531, e13603, e18932, e21623, e21620, e21544; tepotinib (c-Met kinase inhibitor): 9082, 9016; M6620 (ATR inhibitor): 2549, e21048; M3814

Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Heathcare—17 May 18

- Collaboration with Washington University on gut bacteria research could lead to diagnostics, treatment for malnourished children - Study to use Merck's genome-editing technology Merck , a leading science and technology company and leader in genome

BDMS Bangkok Hospital and Samitivej Hospital, win 8 Global Health and Travel Awards for the third Heathcare—16 May 18

For the third consecutive year, Bangkok Hospital and Samitivej Hospital, members of Bangkok Dusit Medical Services (BDMS), won 8 Global Health and Travel Awards (GHT Awards), at the 2018 Asia Pacific Healthcare & Medical Tourism Summit, the leading

Venus Medtech Receives DCP Capital#s Equity Investment to Accelerate Heart Valve Technology Heathcare—16 May 18

Venus Medtech announced that it has entered into a definitive investment agreement with DCP Capital. The investment will be used by Venus Medtech to accelerate the upgrading and internationalization of existing valve products, support the company to

Purpose Driven Approach in Nutrition Spurs Herbalife Nutrition#s Southeast Asia Member Base to Be Heathcare—14 May 18

As a company whose purpose is to make the world healthier and happier, premier global nutrition company, Herbalife Nutrition, has wrapped up Extravaganza, its annual education and training event for the Southeast Asia member community. The three-day

Ascensia Diabetes Care Launches Smarter Version of CONTOUR(R)DIABETES App with New Features to Heathcare—09 May 18

Ascensia Diabetes Care today announced that it has now launched its upgraded version of the CONTOUR(R)DIABETES app in 24 countries worldwide. This latest version includes the new My Patterns feature, which uses innovative algorithms to more intelligently

10 Years of Digital Chest Drainage: Medela#s Milestones Show How State-Of-The-Art Technology Has Heathcare—04 May 18

From Heber-principle to digital systems, thoracic surgery has significantly changed and improved over the course of time - so has chest drainage. Ten years ago, chest drainage therapy as we knew it was completely overhauled with the introduction of

Michele Marin Appointed as New Member of the Italian Board of Directors Heathcare—03 May 18

LimaCorporate has appointed Mr. Michele Marin as a Member of the Italian Board of Directors as of 27th April 2018 in replacement of Daniele Negrato. This appointment follows the previous announcement regarding Michele Marin appointment as CFO of

Werfen increases sales by over 13% and reaffirms its global leadership in in vitro Heathcare—27 Apr 18

Werfen, a global leader in healthcare and life sciences, achieves revenues of 1,337 million euros in 2017, a 13.3% increase against 2016. Excluding the impact of recent acquisitions, sales from organic growth grew by 4.6%. With these results, Werfen

Dutch Biotech Micreos #Alternative to Antibiotics# Wins Ideas From Europe Heathcare—27 Apr 18

In the iconic Hall of Knights, packed with public and policymakers, Dutch biotech Micreos 'sustainable alternative to antibiotics' was chosen as Europe's most relevant innovation, at the finals of the EU's Ideas from Europe competition. Ideas from Europe

Pulsus Expands to Europe, inks deal with 25 Scientific and Healthcare Heathcare—26 Apr 18

Dr. Srinubabu Gedela, CEO of Pulsus and Omics International, announced 2018 Pulsus European expansion Realizing the great potentialities of the European countries, including Germany, Spain, Netherlands, France and Portugal, Pulsus Group announced the

Boehringer Ingelheim has a very successful 2017 financial year Heathcare—25 Apr 18

- Sharp increase in net sales to nearly 18.1 billion euros (+15.7 per cent in currency-adjusted terms; +13.9 per cent in euro terms) - Operating income rises significantly to around 3.5 billion euros - Return on net sales of 19.3 per cent - Strengthened

Merck Receives Patent for CRISPR Technology in China Heathcare—24 Apr 18

- Patent in China covers integration of an external DNA sequence into the chromosome of eukaryotic cells - Company to license CRISPR-related patents to interested parties, supports genome-editing research under ethical and legal standards -

Cell and Gene Therapy Catapult Opens Manufacturing Centre to Accelerate Growth of the Industry in Heathcare—23 Apr 18

- Centre will 'bridge the gap' between scientific research and commercialisation of the medicines of the future - Over GBP60 million of Industrial Strategy investment is being used to develop the new centre Today,the Cell and Gene Therapy Catapult's

Creation of Inceptua Clinical Trial Services Marks New Era for the Heathcare—23 Apr 18

Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of the group's three business units including Clinical Trial Services, Medicines

FDI White Paper and Practical Guide Address the Global Burden of Periodontal Heathcare—23 Apr 18

FDI World Dental Federation published two resources - a white paper and a practical guide - as part of its Global Periodontal Health Project (GPHP), which aims to bring attention to periodontal health as a priority area for policy worldwide. (Logo:

New Research Shows Significant Benefits for COPD Patients in the Home Using Fisher Paykel Heathcare—20 Apr 18

Fisher & Paykel Healthcare Corporation Limited announced today that new research has been published in the International Journal of COPD which demonstrates significant benefits of nasal high flow therapy for COPD* patients using Fisher & Paykel

Swift Biosciences Launches Accel-Amplicon Plus Cancer Panels for Precision Medicine Heathcare—19 Apr 18

- New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus(TM) Cancer